The development of inhibitors of PI3K and Akt

被引：0
|
作者：
Dennis, PA [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [31] The Role of PI3K/AKT Signaling in the Development of Ciona intestinalis
    Evans-Anderson, Heather J.
    Tucker, James
    Intwala, Arti
    FASEB JOURNAL, 2013, 27
  • [32] Imidazopyridazine Inhibitors of PI3Kβ
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1012 - 1013
  • [33] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192
  • [34] PI3K/AKT/mTOR inhibitors would require PI3KCA-mutation analysis
    Lucchetti, Chiara
    Rizzolio, Flavio
    Castronovo, Matteo
    Toffoli, Giuseppe
    PHARMACOGENOMICS, 2011, 12 (10) : 1382 - 1382
  • [35] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [36] Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ
    Miller, Michelle S.
    Mountford, Simon J.
    Pinson, Jo-Anne
    Zheng, Zhaohua
    Kunzli, Marco
    Patel, Vanit
    Hogg, Simon J.
    Shortt, Jake
    Jennings, Ian G.
    Thompson, Philip E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4790 - 4794
  • [37] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [38] PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors
    Wolin, Edward M.
    CANCER LETTERS, 2013, 335 (01) : 1 - 8
  • [39] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
    Wu, P.
    Hu, Y-Z
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (35) : 4326 - 4341
  • [40] Phytochemicals as PI3K/Akt/mTOR Inhibitors and Their Role in Breast Cancer Treatment
    Narayanankutty, Arunaksharan
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2020, 15 (03) : 188 - 199
12345